Skip to main content
TipRanks
Go Ultimate75% OFF

Andrew Hindman Insider Profile

4 Followers

Andrew Hindman, former SVP & CFO at Theravance Biopharma, holds 384.71K shares in Theravance Biopharma (Ticker: TBPH), holds 15.64K shares in Acorda Therapeutics (Ticker: ACORQ).

Andrew Hindman's Trading History

TBPH
Theravance Biopharma
Nov 22, 2022―Uninformative Sell715.65K$6.55M
ACORQ
Acorda Therapeutics
Mar 12, 2019―Uninformative Buy―$203.31

You May Also Like

Andrew Hindman insider profile FAQ

What is the percentage of profitable transactions made by Andrew Hindman?
The percentage of profitable transactions made by Andrew Hindman is 100%.
What is the average return per transaction made by Andrew Hindman?
The average return per transaction made by Andrew Hindman is 38.10%.
What stocks does Andrew Hindman hold?
Andrew Hindman holds: TBPH, ACORQ stocks.
What was Andrew Hindman’s latest transaction?
Andrew Hindman’s latest transaction was an Uninformative Sell of $715.65K.
What was Andrew Hindman's most profitable transaction?
Andrew Hindman’s most profitable transaction was an Informative Sell of ACORQ stock on May 30, 2018. The return on the trade was 64.30%.
What is Andrew Hindman's role in Theravance Biopharma?
Andrew Hindman's role in Theravance Biopharma is SVP & CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.